Research summary, original research, 2013

Surgeon Education Decreases Radiation Dose In Complex Endovascular Procedures And Improves Patient Safety

Kirkwood ML, Arbique GM, Guild JB, Timaran C, Chung J, Anderson JA, et al.. Journal of vascular surgery. 2013

Read the original paper

In plain language

In one hybrid room, educating vascular surgeons on table height, collimation and other technical factors was followed by an estimated 16% lower patient peak skin dose. Fenestrated endovascular aneurysm repair (FEVAR) remained high-dose. Staff dose was not measured.

At a glance

Type of study
Original research, Retrospective cohort study
Who was studied
Vascular surgeons, Patients
Size
n = 300 procedures
Summary based on
the abstract

What it found

  • After surgeon education, the dose index (PSD/RAK ratio) fell, giving an estimated 16% reduction in peak skin dose.

    Key figures: 1.14 to 0.79 (P < .0001); 16% reduction in PSD

  • Education most strongly changed table height, which rose by an average of 10 cm per case.

    Key figures: 10 cm per case (P < .0001)

  • Collimation use increased after education, but this did not lower peak skin dose.

    Key figures: 25% to 40% (P < .001)

  • FEVAR made up most high-dose cases and had significantly higher median RAK than other procedures.

    Key figures: 70% of investigated cases; P < .0001

  • The total number of cases over 6 Gy RAK did not change, but the proportion of non-FEVAR cases over 6 Gy halved.

    Key figures: 40% to 20%

Limits to keep in mind

Single-centre before-after comparison with no control group, and only 300 of 447 procedures had sufficient data (PSD for 122). Outcomes are patient dose metrics; staff occupational dose was not measured.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.